Meyer-Alber A, Höcker M, Fetz I, Fornefeld H, Waschulewski I H, Fölsch U R, Schmidt W E
1st Dept. of Medicine, Christian-Albrechts University Kiel, Germany.
Scand J Gastroenterol. 1995 Apr;30(4):384-91. doi: 10.3109/00365529509093295.
Protein phosphorylation and dephosphorylation events are considered to be key steps in the control of agonist-induced pancreatic enzyme release. This study was designed to characterize the role of serine/threonine phosphatases in phosphoinositol/calcium- and cyclic adenosine monophosphate (cAMP)-mediated stimulus-secretion coupling in rat pancreatic acini.
Isolated rat pancreatic acini were incubated with either the serine/threonine phosphatase inhibitors okadaic acid, calyculin A, and cyclosporin A or the calmodulin antagonist W-7. Amylase secretion was stimulated with cholecystokinin (CCK)-8, secretin, vasoactive intestinal polypeptide (VIP) or pituitary adenylate cyclase-activating polypeptide (PACAP), and the intracellular second messengers calcium and cAMP were determined.
Okadaic acid or calyculin A reduced secretagogue-stimulated amylase release to near-basal levels. Inhibition of cAMP-mediated secretion (by VIP, secretin, or PACAP) occurred at lower concentrations than with inositol triphosphate (IP3)/Ca(2+)-dependent enzyme release (via CCK). Cyclosporin A diminished CCK-8-stimulated secretion by 35%, whereas secretion in response to cAMP-mediated secretagogues was not affected. W-7 completely inhibited acinar secretion in response to cAMP-or IP3/Ca(2+)-mediated secretagogues. Binding of 125I-CCK-8- or 125I-PACAP-(1-27) to acini was not influenced by the phosphatase inhibitors or W-7. Okadaic acid and calyculin A affected neither CCK-8-stimulated intracellular Ca2+ release nor PACAP-(1-27)-stimulated cAMP synthesis, whereas W-7 inhibited by 50% and 40%, respectively.
The inhibitory profiles of okadaic acid, calyculin A, cyclosporin A, and W-7 indicate that phosphatases 1 and 2A play a relevant role in cAMP-mediated enzyme release, whereas phosphatases 1 and 2B are predominantly involved in IP3/Ca(2+)-dependent stimulus-secretion coupling. The calmodulin antagonist W-7 interferes at multiple steps of intracellular signal-transduction pathways.
蛋白质磷酸化和去磷酸化事件被认为是控制激动剂诱导的胰腺酶释放的关键步骤。本研究旨在表征丝氨酸/苏氨酸磷酸酶在大鼠胰腺腺泡中磷酸肌醇/钙和环磷酸腺苷(cAMP)介导的刺激-分泌偶联中的作用。
将分离的大鼠胰腺腺泡与丝氨酸/苏氨酸磷酸酶抑制剂冈田酸、花萼海绵诱癌素A和环孢素A或钙调蛋白拮抗剂W-7一起孵育。用胆囊收缩素(CCK)-8、促胰液素、血管活性肠肽(VIP)或垂体腺苷酸环化酶激活多肽(PACAP)刺激淀粉酶分泌,并测定细胞内第二信使钙和cAMP。
冈田酸或花萼海绵诱癌素A将促分泌剂刺激的淀粉酶释放降低至接近基础水平。与肌醇三磷酸(IP3)/钙(2+)依赖性酶释放(通过CCK)相比,cAMP介导的分泌(由VIP、促胰液素或PACAP)在较低浓度下受到抑制。环孢素A使CCK-8刺激的分泌减少35%,而对cAMP介导的促分泌剂的分泌没有影响。W-7完全抑制了对cAMP或IP3/钙(2+)介导的促分泌剂的腺泡分泌。125I-CCK-8或125I-PACAP-(1-27)与腺泡的结合不受磷酸酶抑制剂或W-7的影响。冈田酸和花萼海绵诱癌素A既不影响CCK-8刺激的细胞内钙释放,也不影响PACAP-(1-27)刺激的cAMP合成,而W-7分别抑制50%和40%。
冈田酸、花萼海绵诱癌素A、环孢素A和W-7的抑制谱表明,磷酸酶1和2A在cAMP介导的酶释放中起相关作用,而磷酸酶1和2B主要参与IP3/钙(2+)依赖性刺激-分泌偶联。钙调蛋白拮抗剂W-7在细胞内信号转导途径的多个步骤中起干扰作用。